MedTrace Logo

Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients

NCT01109134 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2010-04-22

No results posted yet for this study

Summary

The aim of this randomized trial is to compare the efficacy of high dose tirofiban administered as either an intracoronary bolus alone or as an intravenous bolus followed by a maintenance infusion with respect to microvascular perfusion and long term left ventricular infarct size, volumes and function.

Conditions

  • Acute Myocardial Infarction

Interventions

DRUG

tirofiban intracoronary bolus-only

administer tirofiban bolus intracoronary during primary percutaneous coronary intervention with no additional maintenance infusion

DRUG

tirofiban intravenous bolus plus infusion

administer tirofiban bolus intravenously and maintain infusion for up to 18 hours

Sponsors & Collaborators

  • The Society of Cardiac Health Protection

    collaborator UNKNOWN

  • Kosuyolu Heart Hospital

    lead OTHER

Principal Investigators

  • Cevat Kırma, Assoc.Prof · Kosuyolu Heart and Research Hospital

  • Ayhan Erkol, M.D · Kosuyolu Heart and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-02-28
Completion
2009-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01109134 on ClinicalTrials.gov